He further added, "The methylphenidate medicine was essentially a CNS stimulant that was also used as a medicine for rare conditions like ADHD, and is still used. This blue meth is really a ...

A new facility in Utah for the homeless, including services for addiction and mental illness, could be a great success or a ...

Schizoaffective disorder and schizophrenia are separate mental disorders. Learn about both, including symptoms, risk factors, and treatment.

Jennifer Lawrence-Robert Pattinson’s new film Die My Love throws light on postpartum psychosis Our experts give us an insight ...

How can closely related mental illnesses with similar symptoms be reliably distinguished from one another? As part of a German-Chinese collaboration, researchers from Forschungszentrum Jülich and ...

A meta-analysis of 17 studies suggests a potential link between cat ownership and an increased risk of schizophrenia-related ...

The idea that an everyday bond with a pet could intersect with psychiatric research often sparks confused reactions, yet it ...

Medication is the default schizophrenia treatment; however, it may not address key symptoms like social and cognitive ...

A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the first new schizophrenia drug mechanism approved in 50 years.

New theory from the Yolo County District Attorney's Office of cannabis-induced psychosis in the case against Carlos Dominguez ...

Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized psychosis treatment.

Among individuals at clinical high-risk for psychosis (CHR-p), the severity of attenuated delusions may contribute to short-term increases in negative affect (NA) intensity, according to results ...